Aim: The objective of the study was simplest, accurate, precise and robust reversed phase high performance liquid chromatographic (RP-HPLC) method was developed for the estimation of Velpatasvir (VEL) and Sofosbuvir (SOF) in the bulk and its tablet dosage form. Study Design: The Quantitative and Qualitative estimation and designed forced degradation study of Velpatasvir & Sofosbuvir by RP-HPLC. Place and Duration of Study: The study was carried at Santhiram College of Pharmacy and time taken 4 months. Method: The method was attained by used Waters( 5µm, C18 250 x 4.6 mm) column with mobile phase consists of 0.5 mM disodium hydrogen phosphate buffer pH adjusted to 6.5, with Orthophosphoric acid and Methanol in the ratio of 78:22 v/v, a flow rate of 1.0 mL/min and ultraviolet detection at 285 nm. Results: The method was validated as per ICH guidelines with different parameters, the mean retention times of VEL and SOF were found to be 2.8 & 4.7 min respectively. The resolution between VEL and SOF was found to be 10.66. The Correlation coefficients for calibration curves
INTRODUCTION
Hepatitis C virus (HCV) infection is a major public health challenge nowadays. It has been estimated that the global prevalence of HCV infection is around 2%, with 170 million persons chronically infected with the virus and 3 to 4 million persons newly infected each year [1, 2] .
It is a pathogen that is already responsible for a significant proportion of liver disease in various regions of India [3] .
Velpatasvir (VEL) is a novel HCV nonstructural Protein 5A (NS5A) inhibitor that was developed in combination with other drugs, which are directly acting antiviral for the treatment of HCV infections [4] . The IUPAC name for velpatasvir is Methyl {(1R)-2-((2S,4S)-2-(5-{2-((2S,5S) -1-{(2S)-2 -((methoxycarbonyl) amino)-3-methyl butanoyl} -5-methyl pyrrolidin-2-yl)-1,11 dihydro(2) benzopyrano (4',3':6,7) naphtha (1,2-d) imidazol-9-yl}-1H -imidazol -2-yl) -4-(methoxy methyl) pyrrolidin-1-yl)-2-oxo-1-phenylethyl} carbamate. It is a white to off-white powder, slightly soluble in water. It has a molecular formula of C 49 H 54 N 8 O 8 [5] .
Sofosbuvir SOF is a nucleotide pro-drug that effectively inhibits 1-6 HCV RNA replicons in vitro and has proved to have a high sustained virologic response (SVR) rates [5, 6] . Sofosbuvir is a prodrug of 2'-deoxy-2'-fluoro-2'-Cmethyluridine monophosphate that is phosphorylated intra cellularly to the active triphosphate form [7] . Chemically it is (S)-Isopropyl 2-((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-di hydro pyrimidine-1 (2H)-yl) -4-fluoro-3-hydroxy-4-methyl tetrahydrofuran-2-yr)methoxy)(phenoxy)phosphorylamino)propano ate. It is a white to off-white crystalline powder, found to be slightly soluble in water and freely soluble in alcohol and acetone. It has a molecular formula of C 22 H 29 FN 3 O 9 P [8] . Chemical structures of VEL and SOF were shown in Figs.1 and 2 respectively.
The combined dosage form (Tablet -Velpanat, Natco Pharma) consists of 100 mg of VEL and 400 mg of SOF was indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults [4, 6] . LC-MS/MS method has been reported for the estimation of SOF with Ledipasvir in human plasma [9] . Two UPLC-MS/MS methods have been reported for determination of SOF [10] and in a combination of Ledipasvir [11, 12] in human plasma for determination of bioequivalence studies. Few RP-HPLC methods have been reported for the estimation of SOF alone [12, 13] or with a combination of other drugs like Ledipasvir [14, 15] and Simeprevir used in the combination for the treatment of HCV infection [16] .
EXPERIMENTAL

Reagents
All the chemicals and reagents were of analytical grade. Water was redistilled and filtered with a membrane filter. Methanol -HPLC grade (Merck, India), Ortho phosphoric acid and disodium hydrogen phosphate (SD fine chem, India) were used to prepare mobile phase. Pharmaceutical grade standard drugs viz., Velpatasvir and Sofosbuvir were kindly gifted by Natco Pharma Ltd, Hyderabad, India. The combined tablet formulation contains 100 mg of Velpatasvir and 400 mg of Sofosbuvir (Velpanat, Natco) purchased from local market of Nellore.
Chromatographic Conditions
The method was developed by using HPLC system consisted of an LC Waters (Waters, Milford, MA, USA) using a Water's C 18 250 x 4.6 mm, 5µm column, a quaternary gradient system (600 Controller), in line degasser (Waters, model AF). The system was equipped with a photodiode array detector (Waters, 2998 model) and auto sampler (Waters, model 717 plus). Data were processed using Empower Pro software (Waters, Milford, MA, USA). The Isocratic mobile phase consists of a mixture of 0.5 mM disodium hydrogen phosphate buffer pH adjusted to 6.5, with Ortho phosphoric acid and Methanol in the ratio of 78:22% v/v was used throughout the analysis. The mobile phase was pumped at a flow rate of 1.0 mL/min. UV detection wavelength for analytes was The column temperature was kept ambient and the injection volume was 10µL.
Solution Preparation
Standard stock solution preparation
10 mg of VEL and SOF each was weighed accurately and transferred to individual 10 ml volumetric flasks. Dissolved and diluted with methanol to get a concentration of 1000 µg/ml.
Working standard solution
1.625 mL of VEL and 6.25 mL of SOF standard stock solutions were accurately Data were processed using Empower Pro software (Waters, Milford, MA, USA). The Isocratic mobile phase consists of a mixture of disodium hydrogen phosphate buffer pH adjusted to 6.5, with Ortho phosphoric acid and Methanol in the ratio of 78:22% v/v was used throughout the analysis. The mobile phase was pumped at a flow rate of 1.0 mL/min. UV detection wavelength for analytes was 285 nm. The column temperature was kept ambient and
Standard stock solution preparation
10 mg of VEL and SOF each was weighed accurately and transferred to individual 10 ml . Dissolved and diluted with methanol to get a concentration of 1000 µg/ml.
1.625 mL of VEL and 6.25 mL of SOF standard stock solutions were accurately measured and transferred to a 25 mL flask, mixed well and diluted to final volume with a diluent, so as get the final concentrations of 65 µg/mL of VEL and 250 µg/mL of SOF.
Sample solution preparation (Assay)
Twenty tablets were weighed and finely powdered. The average weight of tablets was determined. A portion of powder was weighed equivalent to 10 mg of VEL and transferred to a 10 mL volumetric flask. 10 mL of methanol was added to disintegrate tablets completely by using ultra sonicator for 10 min and solution concentration was 1000 µg/mL.
Working sample solution
The solution was further diluted to get final concentrations of 65 µg/mL of VEL and 250 µg/mL of SOF. This solution was filtered through 0.45 µm membrane filter. The 10µL of this solution was injected into HPLC system.
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measured and transferred to a 25 mL volumetric flask, mixed well and diluted to final volume with a diluent, so as get the final concentrations of 65 µg/mL of VEL and 250 µg/mL of SOF.
Sample solution preparation (Assay)
Twenty tablets were weighed and finely eight of tablets was determined. A portion of powder was weighed equivalent to 10 mg of VEL and transferred to a 10 mL volumetric flask. 10 mL of methanol was added to disintegrate tablets completely by using ultra sonicator for 10 min and solution
The solution was further diluted to get final concentrations of 65 µg/mL of VEL and 250 µg/mL of SOF. This solution was filtered through 0.45 µm membrane filter. The 0µL of this solution was injected into HPLC
Method Validation
The method was validated according to ICH guidelines for the estimation of velpatasvir and sofosbuvir. The following validation parameters are enveloped precision, accuracy, linearity, limit of detection & limit of quantification, robustness and forced degradation studies. The standard solution was prepared at six concentrations ranging from 32.5-97.5µg/mL for VEL and 125-375 µg/mL for SOF solutions were prepared for linearity. The regression of the curve was obtained by peak area vs concentration. The method sensitivity was measured by the limit of detection and limit of quantification. The limit of detection and limit of quantification were determined by signal to noise ratio 3:1& 10:1.The precision of the method was assessed by measured six times standard solution of VEL & SOF and measured the area of all six injections in the HPLC chromatographic system. The accuracy of the method was determined by standard addition and recovery method. The accuracy of the method was evaluated in triplicate at three concentration levels, i.e. 50%, 100% and 150% of target test concentration and the percentages of recoveries were calculated. The robustness of the method was manifested by deliberate changes in experimental conditions. The changes made in the chromatographic conditions like flow rate by ±0.2 mL/min, mobile phase composition of organic phase change ± 3 and the column temperature ±5 °C. The drugs were subjected to different stress conditions like acid (refluxed 0.1N HCl for 1 hr at 80°C), base (refluxed 0.1N NaOH for 4 hrs at 80°C), H 2 O 2 ( stored 3% H 2 O 2 room temp for 2 hrs) light and water near UV ≥200 FOR 10 days) forced degradation studies were conducted on the VEL & SOF.
RESULTS AND DISCUSSION
Method Development and Optimization of Chromatographic Conditions
During the optimization of the method, different columns (Inertsil C8, 250 mm×4.6 mm, 5 µm; Zorbax C18 250 mm×4.6 mm, 5 µm; Symmetry C18 250 mm×4.6 mm, 5 µm) and two organic solvents (acetonitrile and methanol) were tested. The chromatographic conditions were also optimized by using different buffers like phosphate, acetate and citrate for mobile phase preparation. After a series of screening experiments, it was concluded that phosphate buffers gave better peak shapes than their acetate and citrate counterparts. With acetonitrile as solvent both the peaks shows less theoretical plates and more retention time compared to methanol. The chromatographic separation was achieved on a Waters C18, 250 mm×4.6 mm, 5µm column, by using a mixture of 0.5 mM disodium hydrogen phosphate buffer pH adjusted to 6.5, with Ortho phosphoric acid and Methanol in the ratio of 78:22 v/v, as the mobile phase. The temperature was maintained ambient to facilitate mass exchange with the corresponding decrease of peak broadening and increase in sensibility. The flow rate kept was 1.0 mL/min to achieve adequate retention time of two peaks 2.80 min and 4.78 min for VLE and SOF respectively. 
Method Validation
When a method has been optimized it must be validated before practical use. By following ICH guidelines for analytical method validation, Q2 (R1), the validation characteristics were addressed [17] .
System Suitability
The system suitability test ensures the validity of the analytical procedure as well as confirms the resolution between different peaks of interest. All critical parameters tested met the acceptance criteria on all days. As shown in the chromatograms (Figs. 4 & 5) , two analytes were eluted by forming symmetrical single peaks well separated from each other and from excipients. Table 2 shows the System Suitability results.
Linearity
For the construction of calibration curves, five calibration standard solutions were prepared over the concentration range of 32.5 -97.5 µg/ml for VEL and 125.0 -375 µg/mL for SOF. The results, summarized in Table 3 , showed a good correlation between analytes peak area and concentration with r > 0.999 (n = 5). Linearity curve was shown in Figs. 6 and 7.
Precision
The assay was investigated with respect to repeatability and intra-day precision. The repeatability of the system (while keeping the operating conditions identical) was examined by injecting analyte solution with 6 replicate injections. The RSD values varied from 0.47 to 0.86% Showed, that the inter-day precision of the method was satisfactory. Table 4 shows the precision results.
Accuracy
To govern the accuracy of the proposed method, recovery studies have been performed, known amount of pure drug sample solution at three different concentration levels, ie, 50%, 100%,150% was calculated. Accuracy was calculated as a percentage of recovery. The accuracy results tabulated as 5.
Limit of Detection (Lod) and Limit of Quantification (Loq)
The Limit of detection and limit of quantification were considered as the signal-to-noise ratio 3:1 and 10:1 respectively. The limit of detection and limit of quantitation to be determined 0.0068 µg/ml & 0.029 µg/ml for VEL and 0.104 µg/ml & 0.347 µg/ml for SOF respectively. Linearity graph for sofosbuvir
Robustness
The robustness of the method was unaffected when small, deliberate changes like, flow rate change, mobile phase composition, column temperature was performed and compared with normal conditions at 100% test concentration. The method was found to be robust for the said conditions. Results were tabulated in Table 6 .
Analysis of Tablet Formulation
The proposed method was applied for the analysis of velpatasvir and sofosbuvir in tablet dosage forms, the results were found to be between 99.67-100.99%, the results summarized in Table 7 .
Forced Degradation and Stability Indicating Studies
Non-interference of blank and degradants, the developed HPLC method proves the capability stability indicating a method for the analysis of VEL and SOF. Purity angle was less than the purity threshold and hence the proposed method was the specific and revealed its stabilityindicating power. The results were summarized in Table 8 . Fig. 8. (a-e) shows chromatograms of different stress degradation conditions. SOF. Two drugs were subjected to various stress conditions like acid (0.1 N HCl, refluxed for 1 H at 80ºC), base (0.1 N NaOH refluxed for 4H at 80ºC), peroxide (3% H 2 O 2 Stored at room temperature for 2H), water for 6H 80 o C and light (near UV ≥200 for 10 days) stability studies were conducted on these samples. Hence the proposed method was the specific and revealed its stability-indicating power.
CONCLUSION
A simple, specific, precise and accurate isocratic HPLC-UV method was developed for the estimation of velpatasvir and Sofosbuvir in their pharmaceutical formulation. The two compounds were subjected to forced degradation applying several stress conditions. The proposed method was successfully separated two compounds with degradants, estimate the pharmaceutical active contents. The Proposed method was specific and stability-indicating power. Hence the developed method can be adapted to regular quality control analysis.
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